Health Care & Life Sciences » Biotechnology | Geron Corp.

Geron Corp.

Geron Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 183.62 M
Public Float
 139.26 M
Geron Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $0.16
Market Cap
 $261.12 M
Shares Outstanding
 186.52 M
Public Float
 185.19 M

Profile

Address
149 Commonwealth Drive
Menlo Park California 94025
United States
Employees -
Website http://www.geron.com
Updated 07/08/2019
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D.

Financials

View All
Created with Highcharts 5.0.14Geron Corp.Net Income. Fiscal year is January-December. All values USD Thousands.38 37938 37935 67035 670464629 53729 53727 91627 91627 01727 017201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14Geron Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 2831 2831 1531 15336 37136 3716 1626 1621 0651 0651 0661 066201320142015201620172018010k20k30k40k

John A. Scarlett
President, Chief Executive Officer & Director
Daniel Mark Bradbury
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.